KEY POINTS:
Up to $12 million will be available for investing in biotechnology under a new investment partnership.
The partnership involves Crown-owned company New Zealand Venture Investment Fund (NZVIF) and private investment company Pacific Channel, the New Zealand affiliate of United States life sciences venture firm The Channel Group.
Together they would invest around $8 million to $12 million in new biotech ventures, NZVIF said yesterday.
- NZPA
